Skip to main content
Abdullah Kutlar, MD, Oncology, Augusta, GA, Charlie Norwood Veterans Affairs Medical Center

AbdullahKutlarMD

Oncology Augusta, GA

Hematologic Oncology

Professor, Medicine, Medical College of Georgia at Georgia Health Sciences University

Dr. Kutlar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kutlar's full profile

Already have an account?

Education & Training

  • Medical College of Georgia
    Medical College of GeorgiaFellowship, Hematology and Medical Oncology, 1991 - 1992
  • Medical College of Georgia
    Medical College of GeorgiaResidency, Internal Medicine, 1990 - 1991
  • Ankara University FOM
    Ankara University FOMClass of 1971

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1991 - 2025

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Downregulation of Cytoskeletal Protein Kazrin in Lung Endothelial Cells of Preclinical Sickle Cell Disease Mouse Model - Essential Role of Endothelial Barrier Function
    Abdullah Kutlar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Crizanlizumab Treatment Is Associated with Clinically Significant Reductions in Hospitalization in Patients with Sickle Cell Disease: Results from the Sustain Study
    Abdullah Kutlar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies
    Abdullah Kutlar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

Press Mentions

  • New Drug Boosts Foetal Haemoglobin to Fight Sickle Cell Disease
    New Drug Boosts Foetal Haemoglobin to Fight Sickle Cell DiseaseMay 18th, 2023
  • Research Program Aimed at Diversity Brings Young Scientists to MCG Through July 30, 2019
    Research Program Aimed at Diversity Brings Young Scientists to MCG Through July 30, 2019July 17th, 2019
  • Novartis’ Crizanlizumab Relieves Patients from Sickle Cell Pain Crisis
    Novartis’ Crizanlizumab Relieves Patients from Sickle Cell Pain CrisisOctober 10th, 2018
  • Join now to see all

Hospital Affiliations